Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non Operating Income (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Non Operating Income over the past 16 years, most recently at $171000.0 for Q2 2025.

  • For Q2 2025, Non Operating Income rose 115.52% year-over-year to $171000.0; the TTM value through May 2025 reached -$3000.0, up 99.9%, while the annual FY2025 figure was -$3000.0, 99.9% up from the prior year.
  • Non Operating Income for Q2 2025 was $171000.0 at Lifecore Biomedical, Inc. \De\, down from $333000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $736000.0 in Q2 2022 and troughed at -$11.0 million in Q2 2021.
  • A 5-year average of -$752333.3 and a median of -$184000.0 in 2022 define the central range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 355.22% in 2021 and fell as far as 4209.77% in 2021.
  • Year by year, Non Operating Income stood at $330000.0 in 2021, then tumbled by 171.82% to -$237000.0 in 2022, then plummeted by 308.02% to -$967000.0 in 2023, then soared by 68.56% to -$304000.0 in 2024, then surged by 156.25% to $171000.0 in 2025.
  • Business Quant data shows Non Operating Income for LFCR at $171000.0 in Q2 2025, $333000.0 in Q1 2025, and -$304000.0 in Q4 2024.